Literature DB >> 11522660

The neuropeptide pituitary adenylate cyclase-activating polypeptide and islet function.

K Filipsson1, M Kvist-Reimer, B Ahrén.   

Abstract

The neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP) is ubiquitously distributed in both the central and peripheral nervous systems and exerts a variety of effects. PACAP is a neuropeptide in pancreatic islets, where it has been suggested as a parasympathetic and sensory neurotransmitter. PACAP stimulates insulin secretion in a glucose-dependent manner, by an effect executed mainly through augmenting the formation of cAMP and stimulating the uptake of calcium. Accumulating evidence in animal studies points to a physiological importance of PACAP in the regulation of the insulin response to feeding. This review summarizes the current knowledge of islet actions and mechanisms and the function of PACAP.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11522660     DOI: 10.2337/diabetes.50.9.1959

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  17 in total

Review 1.  Trophic effects of PACAP on pancreatic islets: a mini-review.

Authors:  Yusuke Sakurai; Norihito Shintani; Atsuko Hayata; Hitoshi Hashimoto; Akemichi Baba
Journal:  J Mol Neurosci       Date:  2010-07-20       Impact factor: 3.444

2.  What mediates the benefits associated with dipeptidyl peptidase-IV inhibition?

Authors:  B Ahrén
Journal:  Diabetologia       Date:  2005-03-16       Impact factor: 10.122

3.  Adrenal incidentaloma diagnosed as pheochromocytoma by plasma chromogranin A and plasma metanephrines.

Authors:  K Miehle; J Kratzsch; J W M Lenders; R Kluge; R Paschke; C A Koch
Journal:  J Endocrinol Invest       Date:  2005-12       Impact factor: 4.256

4.  Neuropeptide signaling and hydrocephalus: SCO with the flow.

Authors:  David J Picketts
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

Review 5.  Gut peptides and type 2 diabetes mellitus treatment.

Authors:  Bo Ahrén
Journal:  Curr Diab Rep       Date:  2003-10       Impact factor: 4.810

6.  New therapeutic strategies for the treatment of type 2 diabetes mellitus based on incretins.

Authors:  Baptist Gallwitz
Journal:  Rev Diabet Stud       Date:  2005-08-10

7.  Feeding and metabolism in mice lacking pituitary adenylate cyclase-activating polypeptide.

Authors:  Bruce A Adams; Sarah L Gray; Emma R Isaac; Antonio C Bianco; Antonio J Vidal-Puig; Nancy M Sherwood
Journal:  Endocrinology       Date:  2007-12-27       Impact factor: 4.736

Review 8.  Role of ZAC1 in transient neonatal diabetes mellitus and glucose metabolism.

Authors:  Anke Hoffmann; Dietmar Spengler
Journal:  World J Biol Chem       Date:  2015-08-26

9.  Impaired glucose homeostasis in transgenic mice expressing the human transient neonatal diabetes mellitus locus, TNDM.

Authors:  Dan Ma; Julian P H Shield; Wendy Dean; Isabelle Leclerc; Claude Knauf; R éMy Burcelin R; Guy A Rutter; Gavin Kelsey
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

Review 10.  Structure-activity relationship of vasoactive intestinal peptide (VIP): potent agonists and potential clinical applications.

Authors:  Satomi Onoue; Shingen Misaka; Shizuo Yamada
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-01-03       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.